| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/01/2002 | US20020102552 Nucleotide sequences coding preferential polypeptide for use in the treatment of diabetes and eating disorders |
| 08/01/2002 | US20020102540 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 08/01/2002 | US20020102538 Suppressor of HIV replication and transcription |
| 08/01/2002 | US20020102537 Retroviral production |
| 08/01/2002 | US20020102536 Preparation of human or animal herpesviruses |
| 08/01/2002 | US20020102535 Nucleic acid molecules and polypeptides for immune modulation |
| 08/01/2002 | US20020102529 Storage and maintenance of blood products including red blood cells and platelets |
| 08/01/2002 | US20020102272 Composition for delivery of hematopoietic growth factor |
| 08/01/2002 | US20020102270 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 08/01/2002 | US20020102245 14-3-3sigma arrests the cell cycle |
| 08/01/2002 | US20020102244 Obtaining a cell sample which contains a stem cell; detecting the expression of BCRP by a cell in the cell sample; wherein a cell that expresses BCRP is identified as a stem cell |
| 08/01/2002 | US20020102241 Useful for the regeneration of damaged kidney tissue, the generation of artificial kidneys and the delivery of transgenes |
| 08/01/2002 | US20020102239 Methods for storing neural cells such that they are suitable for transplantation |
| 08/01/2002 | DE10102977A1 Testsystem zur Entwicklung von Therapeutika, insbesondere von Wirkstoffen zur Behandlung von Osteoporose Test system for the development of therapeutics, in particular of drugs used to treat osteoporosis |
| 08/01/2002 | DE10100961A1 Körperverträglicher Werkstoff und mit diesem Werkstoff beschichtetes Substrat für die Züchtung von Zellen und künstlichen aus Zellen aufgebauten oder gewachsenen organischen Implantaten Biocompatible material and coated with this material substrate for the growth of cells and artificial or constructed from cells grown organic implants |
| 08/01/2002 | CA2792244A1 A method for identification, isolation and production of antigens to a specific pathogen |
| 08/01/2002 | CA2440703A1 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 08/01/2002 | CA2436091A1 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 08/01/2002 | CA2435949A1 Biological organism for preparing pharmaceutical compositions for treating mammals |
| 08/01/2002 | CA2435826A1 Differentiation of stem cells to pancreatic endocrine cells |
| 08/01/2002 | CA2435776A1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | CA2435510A1 Methods for screening for substances which inhibit fp prostanoid receptor interaction with a compound having pgf2.alpha.alphaactivity and methods of treating cancer |
| 08/01/2002 | CA2435433A1 High level cytokine production with enhanced cell viability |
| 08/01/2002 | CA2435047A1 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | CA2434845A1 Hepatitis c virus replicons and replicon enhanced cells |
| 08/01/2002 | CA2433867A1 Retroviral vectors for transduction into quiescent cells and packaging systems for them |
| 08/01/2002 | CA2433681A1 Sulfatases and methods of use thereof |
| 08/01/2002 | CA2433680A1 Double-stranded rna-mediated gene suppression |
| 08/01/2002 | CA2432134A1 Adenylate cyclases |
| 08/01/2002 | CA2431517A1 Polynucleotides encoding cellular transporters and methods of use thereof |
| 08/01/2002 | CA2431493A1 Aminoacyl trna synthetases |
| 08/01/2002 | CA2431144A1 Cell adhesion proteins |
| 08/01/2002 | CA2430762A1 Colon cancer marker |
| 08/01/2002 | CA2430743A1 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 08/01/2002 | CA2429779A1 Adipocyte complement related protein zacrp13 |
| 08/01/2002 | CA2428084A1 Treatment of inflammatory bowel disease using growth factors |
| 08/01/2002 | CA2427676A1 Dna encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor, cells transformed therewith, and recombinant cell line expressing a human alpha and beta subunits of neuronal nicotinic acetylcholine receptor |
| 08/01/2002 | CA2427647A1 Nucleic acid modification enzymes |
| 08/01/2002 | CA2426102A1 Method of diagnosing and treating cartilaginous disorders |
| 08/01/2002 | CA2333494A1 Blood brain barrier modulation |
| 07/31/2002 | EP1227321A1 Reversible MHC multimer staining for functional purification of antigen-specific T cells |
| 07/31/2002 | EP1227159A1 Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit |
| 07/31/2002 | EP1227152A1 Bacterial strain and genome of bifidobacterium |
| 07/31/2002 | EP1227147A2 Recombinational cloning using engineered recombination sites |
| 07/31/2002 | EP1227146A1 A method for creating endothelial cell dysfunction in cell culture |
| 07/31/2002 | EP1226441A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 07/31/2002 | EP1226436A2 Universal fluorescent sensors |
| 07/31/2002 | EP1226435A1 Axor35, a g-protein coupled receptor |
| 07/31/2002 | EP1226276A2 Diagnostic test for cephalic pain |
| 07/31/2002 | EP1226274A2 Identification of cells for transplantation |
| 07/31/2002 | EP1226265A2 Bioproduction of para-hydroxycinnamic acid |
| 07/31/2002 | EP1226264A2 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 07/31/2002 | EP1226262A2 Regeneration |
| 07/31/2002 | EP1226250A2 Gpcr-kd5 polypeptides and dna sequences thereof |
| 07/31/2002 | EP1226249A2 Follistatin-related protein zfsta4 |
| 07/31/2002 | EP1226248A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 07/31/2002 | EP1226247A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 07/31/2002 | EP1226246A1 Polypeptides with expanded primary signalling motifs |
| 07/31/2002 | EP1226245A2 Hybrid adaptor receptors |
| 07/31/2002 | EP1226244A2 Polypeptides with non-natural primary signalling motifs |
| 07/31/2002 | EP1226243A2 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 07/31/2002 | EP1226239A1 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 07/31/2002 | EP1226236A1 Polypeptides having glucanotransferase activity and nucleic acids encoding same |
| 07/31/2002 | EP1226235A2 Cell constructs that are suitable for immunotherapy, the production and the use thereof |
| 07/31/2002 | EP1226234A2 Hair transplantation |
| 07/31/2002 | EP1226233A2 Multipotent adult stem cells and methods for isolation |
| 07/31/2002 | EP1226232A2 Synthetic substrate for tissue formation |
| 07/31/2002 | EP1226231A1 19 human secreted proteins |
| 07/31/2002 | EP1226177A2 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 07/31/2002 | EP1226175A1 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 07/31/2002 | EP1226174A1 Dna molecules encoding l-glutamate-gated chloride channels from schistocerca americana |
| 07/31/2002 | EP1226171A2 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 07/31/2002 | EP1226169A2 Molecular structure of rhd negative locus |
| 07/31/2002 | EP1226168A1 Ligand activated transcriptional regulator proteins |
| 07/31/2002 | EP1226161A2 Apo-2 receptor antibodies |
| 07/31/2002 | EP1226152A2 Regulation of gene expression by neuroleptic agents |
| 07/31/2002 | EP1226151A2 Gene expression directed by a super-psa promoter |
| 07/31/2002 | EP1226150A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 07/31/2002 | EP1225919A1 Treatment of cancer |
| 07/31/2002 | EP1225906A1 Mechanically elongated neuronal cells and methods for producing and using these cells |
| 07/31/2002 | EP1225877A2 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| 07/31/2002 | EP1225846A2 Bioprosthetic heart valves |
| 07/31/2002 | EP1225801A1 Propagation of human hepatocytes in non-human animals |
| 07/31/2002 | EP1115841A4 Stable neural stem cell lines |
| 07/31/2002 | EP1012235A4 Improved vanillin production |
| 07/31/2002 | EP0850244B1 Toxoplasma gondii glycoconjugates |
| 07/31/2002 | EP0827535B1 Process and articles for producing secondary metabolites of viable plant cells immobilized in a porous matrix |
| 07/31/2002 | EP0825873B1 Anticancer vaccine comprising il6/il6 receptor transfected cells |
| 07/31/2002 | EP0804600B1 The cytoplasmic inhibition of gene expression |
| 07/31/2002 | EP0700297B1 Surrogate tolerogenesis for the development of tolerance to xenografts |
| 07/31/2002 | EP0631633B1 Reaction-based selection for expression of and concentration of catalytic moieties |
| 07/31/2002 | CN1361830A Selecting animals for parentally imprinted traits |
| 07/31/2002 | CN1361825A Novel antifungal agents and fungicides method for the production thereof and their use |
| 07/31/2002 | CN1361823A Global regulators of bacterial pathogenic genes, bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 07/31/2002 | CN1361793A Expression and export of interferon-alpha proteins as Fc fusion proteins |
| 07/31/2002 | CN1361659A A process of cell reprogramming through production of a heterokaryon |
| 07/31/2002 | CN1361244A Discovered chronic granulocyte leukosis related stem and ancestral cell molecule |
| 07/30/2002 | US6426412 Nucleic acids encoding human immunodeficiency virus type 1 genetic suppressor elements |
| 07/30/2002 | US6426411 PGC-1, a novel brown fat pparγ coactivator |
| 07/30/2002 | US6426405 Therapeutic target for treatment of diseases associated with altered muscle activity of pain transmission; has properties of glycine transporter associated with strychnine sensitive glycine receptors--properties called ?sc6? activity |